Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

Afterpay Touch Placement - Still Expensive

Afterpay Placement - We Would Sell Now, Maybe Buy Later, if It Corrects

Latitude Financial Group Pre-IPO Review - Credit Prospectus Throw up Some Interesting Data Points

Australian Credit: Afterpay Touch Launches Its Inaugural High-Yield Bond Issue

Prospa IPO Review - Fintech Company Doesn't Always Mean Better Profitability

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

<p>Afterpay Touch announced an AUD 108 million institutional placement. In this insight, we have a quick look at the deal in the following topics:</p><ul>
<li>Placement details</li>
<li>Company background</li>
<li>Recent earnings</li>
<li>Our thoughts on valuation</li>
<li>Scores in our ECM Framework</li>
</ul>

Afterpay Touch announced an AUD 108 million institutional placement. In this insight, we have a quick look at the deal in the following topics:
Placement details
Company background
Recent earnings
Our thoughts on valuation
Scores in our ECM Framework


Afterpay Touch Placement: Strong Momentum but Valuation Is Rich